Page last updated: 2024-09-05

erlotinib hydrochloride and Papilloma, Squamous Cell

erlotinib hydrochloride has been researched along with Papilloma, Squamous Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batra, RK; Dubinett, SM; Limsukon, A; Soo Hoo, GW; Susanto, I	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Papilloma, Squamous Cell

Article	Year
Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy. Chest, 2009, Volume: 136, Issue:3 Topics: Biopsy; Bronchoscopy; Celecoxib; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Papilloma; Protein Kinase Inhibitors; Pyrazoles; Quinazolines; Sulfonamides	2009

Article

Year

Regression of recurrent respiratory papillomatosis with celecoxib and erlotinib combination therapy.

Chest, 2009, Volume: 136, Issue:3

Topics: Biopsy; Bronchoscopy; Celecoxib; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Papilloma; Protein Kinase Inhibitors; Pyrazoles; Quinazolines; Sulfonamides

2009